CCNE1基因表达状态在卵巢癌中的预后价值(3)
[6] Noske A，Henricksen L A，Lafleur B，et al.Characterization of the 19q12 amplification including CCNE1 and URI in different epithelial ovarian cancer subtypes[J].Exp Mol Pathol，2015，98(1)：47-54.
[7] Kuhn E，Bahadirli-Talbott A，Shih Ie M.Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma[J].Mod Pathol，2014，27(7)：1014-1019.
[8] Amininia S，Hashemi M，Ebrahimi M，et al.Association between CCNE1 polymorphisms and the risk of breast cancer in a sample of southeast Iranian population[J].Med Oncol，2014，31(10)：189.
[9] Ooi A，Oyama T，Nakamura R，et al.Gene amplification of CCNE1，CCND1，and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization[J].Hum Pathol，2017，61(1)：58-67.
[10] Nakayama N，Nakayama K，Shamima Y，et al.Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer[J].Cancer，2010，116(11)：2621-2634.
[11] Pils D，Bachmayr-Heyda A，Auer K，et al.Cyclin E1(CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium[J].Eur J Cancer，2014，50(1)：99-110.
[12] Zhao H，Wang J，Zhang Y，et al.Prognostic Values of CCNE1 Amplification and Overexpression in Cancer Patients：A Systematic Review and Meta-analysis[J].J Cancer，2018，9(13)：2397-2407., http://www.100md.com(黄春珍 郑建清 黄碧芬)
[7] Kuhn E，Bahadirli-Talbott A，Shih Ie M.Frequent CCNE1 amplification in endometrial intraepithelial carcinoma and uterine serous carcinoma[J].Mod Pathol，2014，27(7)：1014-1019.
[8] Amininia S，Hashemi M，Ebrahimi M，et al.Association between CCNE1 polymorphisms and the risk of breast cancer in a sample of southeast Iranian population[J].Med Oncol，2014，31(10)：189.
[9] Ooi A，Oyama T，Nakamura R，et al.Gene amplification of CCNE1，CCND1，and CDK6 in gastric cancers detected by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization[J].Hum Pathol，2017，61(1)：58-67.
[10] Nakayama N，Nakayama K，Shamima Y，et al.Gene amplification CCNE1 is related to poor survival and potential therapeutic target in ovarian cancer[J].Cancer，2010，116(11)：2621-2634.
[11] Pils D，Bachmayr-Heyda A，Auer K，et al.Cyclin E1(CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - a study of the OVCAD consortium[J].Eur J Cancer，2014，50(1)：99-110.
[12] Zhao H，Wang J，Zhang Y，et al.Prognostic Values of CCNE1 Amplification and Overexpression in Cancer Patients：A Systematic Review and Meta-analysis[J].J Cancer，2018，9(13)：2397-2407., http://www.100md.com(黄春珍 郑建清 黄碧芬)